As of November 2024, GlaxoSmithKline has a market cap of $87.13B. This makes GlaxoSmithKline the world's 180th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $90.33B | 14.67% |
2023 | $78.77B | 0.88% |
2022 | $78.09B | -10.52% |
2021 | $87.27B | 19.72% |
2020 | $72.90B | -24.56% |
2019 | $96.63B | 19.30% |
2018 | $81.00B | 12.76% |
2017 | $71.84B | -15.33% |
2016 | $84.85B | 13.77% |
2015 | $74.58B | -0.22% |
2014 | $74.74B | -14.61% |
2013 | $87.54B | 20.71% |
2012 | $72.52B | -9.28% |
2011 | $79.93B | 18.67% |
2010 | $67.36B | -6.03% |
2009 | $71.67B | 2.72% |
2008 | $69.77B | 0.43% |
2007 | $69.47B | -4.84% |
2006 | $73.01B | -8.51% |
2005 | $79.80B | 20.21% |
2004 | $66.38B | -4.53% |
2003 | $69.53B | 7.38% |
2002 | $64.75B | -30.82% |
2001 | $93.59B | -8.84% |
2000 | $102.66B | 8.00% |
1999 | $95.06B | -15.38% |
1998 | $112.33B | 43.61% |
1997 | $78.22B | 51.90% |
1996 | $51.49B | 3.61% |
1995 | $49.70B | 38.22% |
1994 | $35.96B | -8.69% |
1993 | $39.38B | -8.58% |
1992 | $43.08B | -7.03% |
1991 | $46.33B | 101.18% |
1990 | $23.03B | 8.03% |
1989 | $21.32B | 47.00% |
1988 | $14.50B | - |